AGP Picks
View all

Industry Times Tennessee: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Industry Times Tennessee.

Press releases published on May 22, 2026

ARGUS G4 e ARGUS G4 mini di VOOPOO: una sola cartuccia, tre modalità di svapo
VOOPOO’s ARGUS G4 & ARGUS G4 mini: één cartridge, drie vibes
VOOPOO’s ARGUS G4 & ARGUS G4 mini: One Cartridge, Triple Vibes
Novo Announces Director Election Results
Yimutian Inc. Announces Submission of Hearing Request to Nasdaq and Proactive Measures to Regain Full Compliance
Crypto News: AlphaPepe Presale Q2 PancakeSwap Listing Nears as Bitcoin Price Prediction Targets $200,000
FemiCore Claims Evaluated: Investigating the Ingredients for Bladder Support - Femi Core Consumer Complaints Exposed
Most Effective Magnesium Pain Cream Researched: Real Magnesium Niacinamide Relief for Peak Health & Nerve Pain Recovery
CALX INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Calix, Inc.
CTEV SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
YSS SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
OPCH INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Option Care Health, Inc.
QGEN INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Qiagen N.V.
Z INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Zillow Group, Inc.
PHR SHAREHOLDER ALERT: Securities Fraud Lawsuit Filed on Behalf of Phreesia, Inc. Investors - Contact Kirby McInerney LLP by July 13, 2026
Rocket Lab Awarded $90M Contract to Build GEO Satellites Hosting Space Domain Awareness Payload for U.S. Space Force
Ascentage Pharma Releases Latest Clinical Data from Multiple Trials at ASCO 2026

Share this page:

Sign up for:

Industry Times Tennessee

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.